| Nov 11 |
What Makes XOMA Royalty (XOMA) a New Buy Stock
|
| Nov 10 |
XOMA Royalty Corporation (NASDAQ:XOMA) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates
|
| Nov 9 |
XOMA Royalty Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
| Nov 7 |
XOMA Royalty (XOMA) Reports Q3 Loss, Tops Revenue Estimates
|
| Nov 7 |
XOMA Royalty: Q3 Earnings Snapshot
|
| Nov 7 |
XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities
|
| Sep 23 |
Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)
|
| Sep 23 |
XOMA Royalty Declares Quarterly Preferred Stock Dividends
|
| Sep 10 |
High Growth Tech Stocks In The United States To Watch
|
| Aug 18 |
Party Time: Brokers Just Made Major Increases To Their XOMA Royalty Corporation (NASDAQ:XOMA) Earnings Forecasts
|
